Invention Grant
- Patent Title: Polylysine dendrimer contrast agent
- Patent Title (中): 聚赖氨酸树枝状大分子造影剂
-
Application No.: US12377252Application Date: 2007-08-10
-
Publication No.: US09127130B2Publication Date: 2015-09-08
- Inventor: Guy Yeoman Krippner , Zemin Wu , Karlheinz Peter , Christoph Hagemeyer , David Owen
- Applicant: Guy Yeoman Krippner , Zemin Wu , Karlheinz Peter , Christoph Hagemeyer , David Owen
- Applicant Address: AU Abbotsford, Vic AU Melbourne, Vic
- Assignee: STARPHARMA PTY LTD.,BAKER IDI HEART AND DIABETES INSTITUTE HOLDINGS LTD
- Current Assignee: STARPHARMA PTY LTD.,BAKER IDI HEART AND DIABETES INSTITUTE HOLDINGS LTD
- Current Assignee Address: AU Abbotsford, Vic AU Melbourne, Vic
- Agency: Knobbe, Martens, Olson & Bear, LLP
- Priority: AU2006904385 20060811; AU2007901752 20070402
- International Application: PCT/AU2007/001122 WO 20070810
- International Announcement: WO2008/017122 WO 20080214
- Main IPC: A61K9/14
- IPC: A61K9/14 ; C08G83/00 ; A61K47/48 ; A61K49/12 ; A61K49/16 ; C08G69/10 ; C08G73/02 ; C08L77/04
Abstract:
The present invention relates generally to branched macromolecules and their use as imaging or contrast agents. In particular, the invention relates to dendrimers, derived from lysine or lysine analogs, bearing a plurality of functional moieties and their application to imaging techniques in which a disease state may be imaged with a targeted contrast agent.
Public/Granted literature
- US20100278750A1 POLYLYSINE DENDRIMER CONTRAST AGENT Public/Granted day:2010-11-04
Information query
